Hodgkin Disease
Showing 51 - 75 of 91
Factors on Platelet Concentrate Transfusion Response in
Completed
- Lymphoma
- +3 more
- Platelet concentrate transfusion
- (no location specified)
Sep 29, 2017
Hodgkin Disease, Hodgkin's Lymphoma, Lymphoma Trial in Stanford (Gemcitabine, Vinorelbine, Carmustine)
Completed
- Hodgkin Disease
- +2 more
- Gemcitabine
- +5 more
-
Stanford, CaliforniaStanford University School of Medicine
May 15, 2017
Leukemia, Myeloid, Acute, Leukemia, Myelogenous, Chronic, Leukemia, Lymphoblastic, Acute Trial in Saint Louis (AMD3100, Stem
Completed
- Leukemia, Myeloid, Acute
- +7 more
- AMD3100
- Stem Cell Transplant
-
Saint Louis, MissouriWashington University School of Medicine
Jun 5, 2017
Leukemia, Myeloid, Acute, MDS, Lymphoma, Non-Hodgkin Trial in Saint Louis (Sargramostim, Plerixafor)
Completed
- Leukemia, Myeloid, Acute
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
May 3, 2017
Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone
Unknown status
- Chronic Kidney Disease
- +16 more
- Haploidentical Bone Marrow/Kidney
-
Boston, MassachusettsMassachusetts General Hospital
Mar 21, 2017
Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in St. Louis (AMD3100, G-CSF, Apheresis)
Completed
- Lymphoma, Non-Hodgkin
- Hodgkin Disease
- AMD3100
- +2 more
-
St. Louis, MissouriWashington University School of Medicine
Jan 26, 2017
Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Palo Alto (SD-101, Local Radiation)
Terminated
- Lymphoma, Non-Hodgkin
- Hodgkin Disease
- SD-101
- Local Radiation
-
Palo Alto, CaliforniaStanford University School of Medicine
Nov 17, 2016
GVHD, MDS, Leukemia Trial run by the NHLBI (RFT5-SMPT-dgA, Isolex system)
Completed
- Graft vs Host Disease
- +9 more
- RFT5-SMPT-dgA
- Isolex system
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 21, 2016
Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in Lexington (Azacitidine with rituximab, vincristine, and
Completed
- Lymphoma
- +2 more
- Azacitidine with rituximab, vincristine, and cyclophosphamide
-
Lexington, KentuckyUniversity of Kentucky
Oct 13, 2016
Hodgkin Disease, Breast Cancer Trial in Marseille (intensive screening)
Terminated
- Hodgkin Disease
- Breast Cancer
- intensive screening
-
Marseille, FranceFrançois EISINGER, PhD
Oct 13, 2016
Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Riyadh (Cytogenetic Analysis of Bone Marrow Specimen)
Completed
- Lymphoma, Non-Hodgkin
- Hodgkin Disease
- Cytogenetic Analysis of Bone Marrow Specimen
-
Riyadh, Saudi ArabiaKFSH&RC
Dec 16, 2015
Lymphoma, Non-Hodgkin, Hodgkin Disease Trial (FDG PET)
Completed
- Lymphoma, Non-Hodgkin
- Hodgkin Disease
- FDG PET
- (no location specified)
Dec 16, 2015
B-Receptor Signaling in Cardiomyopathy
Completed
- Carcinomas
- +37 more
-
Stanford, CaliforniaStanford University School of Medicine
Nov 16, 2015
Hodgkin Disease, Non-Hodgkin Lymphoma, Multiple Myeloma Trial in Köln (moxifloxacin, )
Completed
- Hodgkin Disease
- +3 more
- moxifloxacin
- placebo
-
Köln, GermanyKlinikum der Universität zu Köln
Jun 1, 2015
Haploidentical Graft Recipients
Completed
- Leukemia
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Mar 9, 2015
Leukemia, Myeloid, Acute, MDS, Leukemia, Lymphoblastic, Acute Trial in London (Thiotepa, Fludarabine, Intravenous busulphan)
Terminated
- Leukemia, Myeloid, Acute
- +5 more
- Thiotepa
- +8 more
-
London, United KingdomKing's College Hosptial NHS Foundation Trust
Feb 10, 2015
Hodgkin Disease Trial in Stanford (Doxorubicin, Vinblastine, Cyclophosphamide)
Terminated
- Hodgkin Disease
- Doxorubicin
- +8 more
-
Stanford, CaliforniaStanford University Medical Center
Aug 26, 2014
Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Atlanta (G-CSF plus plerixafor, rituximab)
Completed
- Non-Hodgkin Lymphoma
- Hodgkin Disease
- G-CSF plus plerixafor
- rituximab
-
Atlanta, GeorgiaWinship Cancer Institute
Feb 10, 2014
Acute Myeloid Leukemia, Myelodysplasia, Acute Lymphoblastic Leukemia Trial in San Francisco (umbilical cord stem cells)
Terminated
- Acute Myeloid Leukemia
- +9 more
- umbilical cord stem cells
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 13, 2013
Leukemia, Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in St. Louis (CD34-TK75 transduced donor lymphocytes, Sub Study - 18 FHBG
Completed
- Leukemia
- +4 more
- CD34-TK75 transduced donor lymphocytes
- Sub Study - 18 FHBG PET/CT Scans
-
St. Louis, MissouriWashington University School of Medicine
Jul 9, 2013